BREAKING — Emergency Room Visits Surge 20% Among mRNA Vaccinated Teens, Study Finds

Written by Nicolas Hulscher, MPH on April 29, 2025. Posted in Current News

Overview:

Population: 105,726 vaccinated adolescents (age 12-18) vs 23,132 unvaccinated matched controls.

Vaccine Studied: Pfizer-BioNTech BNT162b2 (COVID-19 mRNA injection).

Design: Real-world national registry study; healthcare use compared before and after vaccination.

Method: Prior Event Rate Ratio (PERR) analysis adjusting for prior healthcare use.

Outcomes Measured:

• Emergency Room (ER) visits
• General Practitioner (GP) visits
• Specialist Practitioner (SP) visits
• Hospitalizations

0–21 Days After First Dose

In the first 0–21 days after the first vaccine dose, the study found higher, non-statistically significant rates of the following among the vaccinated:

• Emergency Room (ER) visits:
  • Boys: +4% (PERR 1.04, 95% CI: 0.91–1.19)
• Hospitalizations:
  • Boys: +18% (PERR 1.18, 95% CI: 0.78–1.72)

0–56 Days After Second Dose

In the first 0–56 days after the second vaccine dose, the study found higher, non-statistically significant rates of the following among the vaccinated:

• Emergency Room (ER) visits:
  • Girls: +10% (PERR 1.10, 95% CI: 0.97–1.28)
  • Boys: +8% (PERR 1.08, 95% CI: 0.98–1.20)
• Hospitalizations:
  • Girls: +26% (PERR 1.26, 95% CI: 0.96–1.67)
• General Practitioner (GP) visits:
  • Girls: +2% (PERR 1.02, 95% CI: 0.98–1.07)
  • Boys: +3% (PERR 1.03, 95% CI: 0.98–1.08)

LONG TERM: 57–182 Days After Second Dose

In the 57–182 days after the second vaccine dose, the study found higher, statistically significant rates of the following among the vaccinated:

• Emergency Room (ER) visits:
  • Girls: +22% (PERR 1.22, 95% CI: 1.08–1.39)
  • Boys: +17% (PERR 1.17, 95% CI: 1.07–1.31)
• General Practitioner (GP) visits:
  • Girls: +17% (PERR 1.17, 95% CI: 1.12–1.21)
  • Boys: +17% (PERR 1.17, 95% CI: 1.13–1.22)
• Specialist Practitioner (SP) visits:
  • Boys: +23% (PERR 1.23, 95% CI: 1.08–1.39)
  • (Girls: non-significant increase, PERR 1.10, 95% CI: 0.98–1.21)

Unfortunately, specific diagnoses for the healthcare visits were not identified in the study. Although some early increases were not statistically significant, the long-term increases among the vaccinated were consistent and significant for emergency room and general practitioner visits.

The rise in healthcare visits likely reflect persistent symptoms, adverse reactions, or health concerns following vaccination. These results are not surprising given that COVID-19 mRNA injections induce chronic disease: After intramuscular injection, lipid nanoparticles distribute throughout the ENTIRE body and install Pfizer/Moderna modified genetic code into vital organ systems — turning them into toxic Spike protein production factories for years:

BREAKING STUDY: Intramuscular mRNA Injections Distribute to Vital Organs, Resulting in Systemic Spike Protein Production

BREAKING STUDY — COVID-19 mRNA Injection Spike Protein Expressed in Cerebral Arteries of Stroke Patients for Up to 17 Months

See more here The Focal Points

Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.